The new drug would allow patients to produce the needed clotting protein for an extended period, reducing the need for constant intravenous infusions or injections, which are painful as well as inconvenient.
More Stories
Boeing to lay off thousands of workers, warns of quarterly loss and weaker sales
Boeing surprised markets late Friday with news that it plans to cut about 10% of its workforce, and warned investors...
End-of-life decisions can be impossibly hard. But the right senior-care team can make things a little easier.
Don’t let palliative care decisions tear your family apart. Here’s how to put together your best senior-care team.
Amazon faces $1.5 billion Project Kuiper headwind in 2025 after satellite launch delay: Morgan Stanley
Amazon’s ambitious Project Kuiper satellite constellation aims to build a system of 3,236 satellites to increase global broadband access.
Here’s how stocks have performed under Biden and Harris vs. under Trump
During the homestretch of the tight presidential race, the campaigns of Democratic nominee Kamala Harris and Republican rival Donald Trump...
Hurricanes Helene and Milton unlikely to depress U.S. GDP
Hurricanes Milton and Helene put lots of people out of work temporarily and could add upward pressure to inflation, but...
Can Nvidia have another blowout year in 2025?
Also: New ways to learn about financial risks before buying a home, thoughts on the bull market for stocks and...